FOR THIS DISCUSSION DISCUSSION POST respond by providing recommendations for alternative drug treatments to address the patient’s pathophysiology. Be specific and provide examples. References that are evidence-based research within 5 years are needed. This is also to be in APA 7ed format.
[Solution] Acquired Pneumonia and Alternative treatments
Community acquired pneumonia (CAP) develops outside the hospital and is caused by multiple microbes including fungi, viruses, and bacteria (Jensen et al., 2017). The most common comorbidities are chronic respiratory diseases and diabetes among others (Metlay et al., 2019). As such, treatment should involve the management of pneumonia as well as other disorders that increased the risk of fatality for the patient. This paper explores alternative treatments for a patient diagnosed with CAP and a history of multiple comorbidities.
First, I suggest that the client should first undergo chest radiography to determine his severity index. This will inform the treatment regime selected. With this information, I will begin the patient with doxycycline. This is the first line of treatment for CAP. The patient will receive a prescription of 100 mg PO every 12 hours orally for at least 5 days (Pinzone et al., 2014). This will be part of combination therapy for the patient following his comorbidities which include past medical history of chronic obstructive pulmonary disease, hypertension, hyperlipidemia, and diabetes.
Tetracycline antibiotics such as Doxycycline treat illnesses caused by bacteria by preventing their growth and spread. This makes it a highly effective antibiotic in the treatment of respiratory tract infections. Considering that the client has a history of COPD, this drug will also help manage the condition since this dosage is also used to treat acute exacerbations in COPD. For such cases, this 100mg of doxycycline short-acting bronchodilator inhaler is taken for 7 to 10 days as a first-line treatment for COPD (Pletz et al., 2016). Therefore, this is the best treatment option for the client since it will treat his community acquired pneumonia and at the same time manage his Chronic obstructive pulmonary disease thus improving his outcome. Doxycycline has also demonstrated significant improvement in the management of diabetes and the reduction of its risks.
Jensen, A. V., Egelund, G. B., Andersen, S. B., Trier Petersen, P., Benfield, T., Faurholt-Jepsen, D., Ravn, P. (2017). The impact of blood glucose on community-acquired pneumonia: a retrospective cohort study. ERJ Open Research, 3(2), 00114–2016. https://doi.org/10.1183/23120541.00114-2016
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., … & Whitney, C. G. (2019). Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine, 200(7), e45-e67.
Pletz, M. W., Rohde, G. G., Welte, T., Kolditz, M., & Ott, S. (2016). Advances in the prevention, management, and treatment of community-acquired pneumonia. F1000Research, 5, 300. https://doi.org/10.12688/f1000research.7657.1
Pinzone, M. R., Cacopardo, B., Abbo, L., & Nunnari, G. (2014). Duration of Antimicrobial Therapy in Community Acquired Pneumonia: Less Is More. The Scientific World Journal, 2014, 1–8. https://doi.org/10.1155/2014/759138